Literature DB >> 2550046

Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes.

A Martinsson1, K Lindvall, A Melcher, P Hjemdahl.   

Abstract

1. Different techniques of assessing beta-adrenoceptor sensitivity in vivo, by use of i.v. infusions or bolus injections of isoprenaline (ISO), were compared in healthy volunteers. The importance of autonomic reflexes for responses to ISO was evaluated by studying the influence of 'autonomic blockade' by atropine and clonidine, which antagonize muscarinic effects and reduce sympathetic activity, respectively. Estimates of in vivo responsiveness to ISO were compared with parameters reflecting beta 2-adrenoceptor function in vitro in lymphocytes. 2. Heart rate responses to infused ISO were not significantly altered by 'autonomic blockade' when evaluated from concentration-effect curves. When related to the infused dose of ISO, however, sensitivity was artefactually increased (P less than 0.05), as the plasma concentrations of ISO were 40% higher after atropine and clonidine. Heart rate responses to bolus injections of ISO were attenuated (P less than 0.05) by 'autonomic blockade', suggesting that facilitatory reflexes contribute to these non-steady state responses. Intersubject variations in heart rate responsiveness to ISO were greater than the intrasubject variability caused by counterregulatory reflexes. 3. 'Autonomic blockade' lowered venous plasma noradrenaline at rest. The noradrenaline response to ISO infusion was attenuated and the diastolic blood pressure response enhanced, indicating that a counterregulatory vasoconstrictor reflex normally is activated by ISO-induced vasodilatation. The plasma cyclic AMP response to ISO, on the other hand, was unaffected by atropine and clonidine and reflects beta 2-adrenoceptor responsiveness in vivo. 4. In vitro data for beta-adrenoceptor binding sites (Bmax;[125I]-IHYP binding) and cyclic AMP responses to ISO in lymphocytes correlated with DBP and noradrenaline responses to infused ISO. No correlations were found between in vitro data and heart rate, plasma cyclic AMP or plasma glycerol responses to infused ISO in vivo. 5. During prolonged ISO infusions (in six other healthy subjects) physiological responses reached greater than 90% of their steady state level after 8 min, but no definite steady state level could be defined for the plasma concentration of ISO during 40 min of infusion. 6. The ISO infusion test showed a good reproducibility, especially when repeated on the same day. Evaluation of plasma concentration-effect relationships increase the precision of the ISO infusion test as confounding inter- and intra-individual variations in ISO concentrations (as caused by e.g. autonomic blockade) will be taken into account.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550046      PMCID: PMC1379974          DOI: 10.1111/j.1365-2125.1989.tb03509.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  26 in total

1.  Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method.

Authors:  P Hjemdahl; M Daleskog; T Kahan
Journal:  Life Sci       Date:  1979-07-09       Impact factor: 5.037

2.  Actions of salbutamol in late pregnancy: plasma cyclic AMP, insulin and C-peptide, carbohydrate and lipid metabolites in diabetic and non-diabetic women.

Authors:  B B Fredholm; N O Lunell; B Persson; J Wager
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

Review 3.  Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system.

Authors:  P E Cryer
Journal:  N Engl J Med       Date:  1980-08-21       Impact factor: 91.245

4.  Reduced beta-adrenoceptor sensitivity in the elderly.

Authors:  R E Vestal; A J Wood; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

5.  Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection.

Authors:  P Hjemdahl
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Saturation assay for cyclic AMP using endogenous binding protein.

Authors:  B L Brown; R P Ekins; J D Albano
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

7.  An enzymatic fluorometric micromethod for the determination of glycerol.

Authors:  S Laurell; G Tibbling
Journal:  Clin Chim Acta       Date:  1966-03       Impact factor: 3.786

8.  Intravenously administered isoproterenol sulfate dose-response curves in man.

Authors:  C F George; M E Conolly; T Fenyvesi; R Briant; C T Dollery
Journal:  Arch Intern Med       Date:  1972-09

9.  A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol.

Authors:  C R Cleaveland; R E Rangno; D G Shand
Journal:  Arch Intern Med       Date:  1972-07

10.  Contribution of cardiovascular reflexes to differences in beta-adrenoceptor-mediated responses in essential hypertension.

Authors:  G Jennings; A Bobik; M Esler; P Korner
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

View more
  10 in total

1.  Confirmation of a role for the 389R>G beta-1 adrenoceptor polymorphism on exercise capacity in heart failure.

Authors:  A J Sandilands; J Parameshwar; S Large; M J Brown; K M O'Shaughnessy
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

2.  Insulin responses to glucose and isoproterenol decrease with age.

Authors:  James M Watters
Journal:  Can J Surg       Date:  2005-04       Impact factor: 2.089

Review 3.  The functional significance of genetic variation within the beta-adrenoceptor.

Authors:  A J Sandilands; K M O'Shaughnessy
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

4.  Beta-receptor responsiveness after desipramine treatment.

Authors:  R Pohl; G N Pandey; V K Yeragani; R Balon; J M Davis; R Berchou
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Bolus isoproterenol infusions provide a reliable method for assessing interoceptive awareness.

Authors:  S S Khalsa; D Rudrauf; C Sandesara; B Olshansky; D Tranel
Journal:  Int J Psychophysiol       Date:  2008-09-27       Impact factor: 2.997

6.  Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium.

Authors:  A J Sandilands; K M O'Shaughnessy; M J Brown
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 7.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

8.  Systemic β-adrenergic stimulation of thermogenesis is not accompanied by brown adipose tissue activity in humans.

Authors:  Maarten J Vosselman; Anouk A J J van der Lans; Boudewijn Brans; Roel Wierts; Marleen A van Baak; Patrick Schrauwen; Wouter D van Marken Lichtenbelt
Journal:  Diabetes       Date:  2012-08-07       Impact factor: 9.461

9.  The Application of Dynamic Models to the Exploration of β1-AR Overactivation as a Cause of Heart Failure.

Authors:  Xiaoyun Wang; Min Zhao; Xiaoqiang Wang; Shuping Li; Ning Cao; Huirong Liu
Journal:  Comput Math Methods Med       Date:  2018-07-30       Impact factor: 2.238

10.  Effect of adrenergic agonists on coronary blood flow: a laboratory study in healthy volunteers.

Authors:  Alvaro F Vargas Pelaez; Zhaohui Gao; Tariq A Ahmad; Urs A Leuenberger; David N Proctor; Stephan R Maman; Matthew D Muller
Journal:  Physiol Rep       Date:  2016-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.